Angiocrine Bioscience

0 followers


Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function and rejuvenate patients with serious medical conditions.

Industries

Headquarters

Stage

Employees

Links

Org chart

Paul Finnegan

Collapse
John K. Fraser
Chief Scientific Officer
Jeannette Filippone
General Counsel
Shawn Sheeron
VP, Clinical Operations
Lee Landeen
Executive Director, Pre-clinical Development
Michael Ginsberg
Senior Director, Product Development
Margie Breneman
Senior Director, Project Management
Daniel J. Nolan
Director, External Research
Geoff Davis
President And CSO
Doreen G.
Vice President Medical Affairs